Watch: Innovation in Deodorants Webinar
Our joint ‘Innovation in Deodorants’ webinar with Cosmetics Cluster UK (CCUK) looked at innovation trends and market opportunities in deodorants, translational research in skin microbiome/biofilms, in vitro alternatives to animal testing, new technology and small brand perspectives and promoting consumer health and sustainability.
The full webinar is now available to watch, and pdf presentations are available for download on this page.
Future Fresh – Innovations, Improvements, and Ideas for the next Decade of Deodorants and Antiperspirants: Deanna Utroske.
In our modern moment, wellness, hygiene, and aroma are more central than ever. And there’s a big opportunity here for deodorants and antiperspirants to take on new importance in the marketplace and meet beauty consumer expectations head on. In this presentation, personal care industry thought leader Deanna Utroske shared insights on the trends and opportunities on track to impact the future of the deo and antiperspirant category for and beyond underarm care. and discussed emerging ingredient technologies, new microbiome science and novel product formats.
In vitro assessment of the mildness of deodorant formulations to human skin: Dr Carol Treasure – Founder & CEO, XCellR8.
Deodorants contain both synthetic and natural ingredients capable of causing irritant or allergic contact dermatitis. Understanding the kindness of a new deodorant formulation to skin extends beyond the basic safety assessment requirement. Thorough evaluation at an early stage in new product development can help to optimise formulations to reduce the likelihood of reactions in subsequent clinical trials and provide valuable claim support data in a world where consumers are demanding increasingly mild products. In this talk Carol looked at the latest developments in test methods for skin irritation and sensitisation using human-relevant in vitro science, with a particular focus on a new test for skin mildness and its application in testing deodorant ingredients and formulations. Importantly, and focused on how the results can be placed into context through comparison with benchmark data. She also showed how the tests can support vegan-compliant testing programmes for the development of vegan product ranges.
Challenging body odour with a biological approach: Daniel Robustillo – Business Manager, Vytrus Biotech.
New deodorant mechanism of action combining an innovative prebiotic technology and the latest advances in plant stem cell technology for the skin microbiota treatment. It has been demonstrated how to modulate body malodour while being respectful with the skin microbiota and its ecosystem. The mechanism of action has been evaluated by performing several in vitro and in vivo tests to demonstrate the effective body odour reduction while allowing the natural axillary perspiration.
Is the study of Pharmacognosy relevant in todays formulary for personal care products: Dr Simon Jackson – CSO & Co Founder, Modern Botany.
Many people ask this question and the answer is of course Yes! The study of Pharmacognosy is more relevant now than ever in the Industry of cosmetics and personal care products. The study of Pharmacognosy will be explained including the overview of what is included in the contemporary studies. Dr Jackson explained his background briefly, the centres of excellence in the UK and how he became one of the last practising Pharmacognosist’s in the UK. In the ever increasing usage of natural products in personal care, Dr Jackson explained how he broke down the current commercial offerings into its basic elements and then built it up again using Pharmacopeia grade natural extracts, and walked through, at a high level, the ingredients he chose and reasons why, followed by an overview of the clinical testing that they have undertaken on the recently launched and Award winning Modern Botany natural deodorant.